Covid-19 current prevalence
Pro Research Analysisby 
Searched over 200M research papers
COVID-19 Prevalence: Global and Regional Estimates
Current estimates suggest that COVID-19 has infected a significant portion of the global population, with some studies indicating that up to 10% of people worldwide have been affected at some point during the pandemic . Regional studies, such as one conducted in Ohio, USA, found that the prevalence of current COVID-19 infection among adults was about 0.9% during July 2020, while the prevalence of past infection was 1.3% . These numbers highlight that actual infection rates are often several times higher than the number of diagnosed cases, due to limited early testing and asymptomatic cases .
Prevalence of Symptoms and Comorbidities in COVID-19 Patients
Common Symptoms
Fever is the most frequently reported symptom among COVID-19 patients, with prevalence rates ranging from 79% to 85% in adults Hu2020Islam2021. Other common symptoms include cough (66%), fatigue (42%), and shortness of breath (21%) . In children, fever is less common, affecting about 46% of pediatric cases .
Underlying Health Conditions
Hypertension, diabetes, and cardiovascular diseases are the most prevalent comorbidities among hospitalized COVID-19 patients. Hypertension affects about 16–27% of patients, diabetes 7–17%, and cardiovascular disease 5–12% Hu2020Emami2020Bajgain2020. The presence of these conditions is associated with increased severity of illness, though not necessarily with higher fatality rates Hu2020Bajgain2020. Other notable comorbidities include chronic obstructive pulmonary disease (COPD), cancer, and chronic kidney disease Emami2020Bajgain2020.
Smoking Prevalence
The prevalence of current smoking among hospitalized COVID-19 patients in China was found to be unexpectedly low, at around 6.5–7.3%, which is much lower than the general population smoking rate . This finding has prompted further investigation into the relationship between smoking, nicotine, and COVID-19 outcomes .
Mental Health and Neurological Impact During the COVID-19 Pandemic
Mental Health Disorders
The pandemic has led to a significant increase in mental health disorders. The prevalence of depression, anxiety, and sleep disturbances among COVID-19 patients is high, with pooled estimates of 45% for depression, 47% for anxiety, and 34% for sleep disturbances . In the general population, the prevalence of depression and anxiety during the pandemic has been estimated at around 16% and 15%, respectively, with insomnia affecting about 24% . Mental health issues have been especially pronounced among young adults, students, and those facing economic hardship .
Neurological Disorders
COVID-19 has also been linked to a higher prevalence of neurological disorders. Among infected individuals, the prevalence rates are approximately 3.4% for stroke, 6.4% for dementia, 4% for multiple sclerosis, and 5.4% for epilepsy . These conditions are associated with increased mortality risk in COVID-19 patients .
Conclusion
COVID-19 continues to have a significant global prevalence, with actual infection rates often exceeding reported cases. Fever remains the most common symptom, and underlying conditions such as hypertension and diabetes are widespread among patients. The pandemic has also led to a notable rise in mental health and neurological disorders, affecting both patients and the general population. Ongoing surveillance and targeted interventions are essential to address the evolving impact of COVID-19 on public health.
Sources and full results
Most relevant research papers on this topic